- Home
- / Norris Medicines
Norris Medicines
Stock Price
₹13.2
2024-08-23
Revenue
₹58.2 M
FY, 2025
Norris Medicines Summary
Company Summary
- Overview
- Norris Medicines is a manufacturer and supplier of generic pharmaceutical products. Its products include tablets, capsules, syrups, ointments, etc.
- Type
- Public
- Status
- Active
- Website
- https://www.norrispharma.com
- Cybersecurity rating
- Sectors
Table of Contents
Norris Medicines Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹32.7M
- Gross profit (Q3, 2026)
- ₹18.5M
- Net income (Q3, 2026)
- ₹7.0M
- Cash (Q2, 2026)
- ₹646.0K
- EBIT (Q3, 2026)
- ₹8.2M
- Enterprise value
- $214.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026